SOP-009 / SOP v2.0
Oral solutions, syrups and suspensions
Non-sterile oral liquids under a specifically approved master record.
Procedure
- Check solubility or the need for suspension, patient suitability of excipients and the exact active-substance form.
- Verify water and vehicle quality. Sugar or preservative presence alone does not establish microbiological stability.
- Follow the specific dissolution, wetting and dispersion sequence. Record temperature, time and mixing; do not transfer settings from another product.
- Clarify whether the source requires final mass, final volume or addition of a specified vehicle. Check temperature before final volumetric adjustment where relevant.
- Apply suitable appearance, pH, yield, redispersibility and uniformity checks. Observations do not replace required quantitative analysis.
- Check container and dosing-device compatibility. Shaking instructions must reflect demonstrated redispersibility and be understandable to the user.
Edition-specific detail
Verify mg/mL and the exact starting tablet or bulk-material form. Modified-release or enteric-coated products cannot arbitrarily replace the specified starting material. For suspensions establish justified shaking and a suitable oral syringe; assess redispersibility after representative standing, not only immediately after mixing.
Stop criterion
Irreversible settling, separation, unsupported BUD or uncertain final strength: quarantine.
Related forms
Sources and references
- NAPRA — Model Standards for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 4–9Risk, personnel, facilities and QA; its historical BUD table is not used for current USP defaults2026-09-12
- NAPRA — Guidance Document for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 5, 6 and 7; master/batch records, delivery, qualityQuality-system implementation; historical BUD table not substituted for 2022 USP revision2026-09-12
- PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12